In the SUMMIT study (Surrogate Markers for Micro-and Macrovascular Hard Endpoints for Innovative Diabetes Tools), we have previously shown that KIM-1 was the most useful of a wide range of biomarkers associated with eGFR loss in type 2 diabetes [14]. Here, HAVCR1 is linked to type 2 diabetes mellitus.